SCHEMBL29908941

SCHEMBL29908941

CN(Cc1ccc(N)cc1)C(=O)OC(C)(C)C.CNCc1ccc(NC(=O)CCCCCCC(=O)OC(C)(C)C)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 8/20 0.50
HDAC3 O15379 6/20 0.39
NCOR2 Q9Y618 1/20 0.39
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
HDAC1 Q13547 5/20 0.36
HDAC2 Q92769 5/20 0.36
HDAC10 Q969S8 5/20 0.36
HDAC4 P56524 4/20 0.36
HDAC7 Q8WUI4 4/20 0.36
HDAC11 Q96DB2 4/20 0.36
HDAC6 Q9UBN7 4/20 0.36
HDAC9 Q9UKV0 4/20 0.36
HDAC5 Q9UQL6 4/20 0.36
BCHE P06276 2/20 0.36
ACHE P22303 2/20 0.36
GPR4 P46093 1/20 0.36
TRPV1 Q8NER1 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
ENPP2 Q13822 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29908969 0.89 HDAC8 (0.57) HDAC8HDAC3NCOR2CA1CA2
SCHEMBL24880999 0.85 HDAC8 (0.61) HDAC8HDAC3NCOR2CA1CA2
SCHEMBL29908950 0.84 HDAC8 (0.51) HDAC8HDAC3NCOR2HDAC1HDAC2
SCHEMBL29908939 0.81 HDAC8 (0.47) HDAC8HDAC3NCOR2CA1CA2
SCHEMBL2227505 0.76 HTR2C (0.41) HDAC3NCOR2HDAC1HDAC2
SCHEMBL18392619 0.75 BCHE (0.43) HDAC8CA1CA2BCHEACHE
SCHEMBL24882016 0.75 HDAC8 (0.53) HDAC8HDAC3NCOR2CA1CA2
SCHEMBL29908940 0.74 HDAC8 (0.56) HDAC8HDAC3NCOR2CA1CA2
SCHEMBL24881075 0.74 HDAC8 (0.63) HDAC8HDAC3NCOR2CA1CA2
SCHEMBL24881437 0.74 HDAC8 (0.58) HDAC8HDAC3NCOR2HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4054607-A1 SELECTIVE HDAC6 DEGRADERS AND METHODS OF USE THEREOF Dana-Farber Cancer Institute, Inc. (US) 2022-09-14 EP disclosed